Generic placeholder image

Current Pharmaceutical Biotechnology

Editor-in-Chief

ISSN (Print): 1389-2010
ISSN (Online): 1873-4316

Cell Sheet Technology for Heart Failure

Author(s): Yoshiki Sawa and Shigeru Miyagawa

Volume 14, Issue 1, 2013

Page: [61 - 66] Pages: 6

DOI: 10.2174/1389201011314010009

Price: $65

Abstract

Heart failure is a life threatening disorder in worldwide and many papers reported about myocardial regeneration through surgical method induced by LVAD, cellular cardiomyoplasty (cell injection), tissue cardiomyoplasty (bioengineered cardiac graft implantation), in situ engineering (scaffold implantation), and LV restrictive devices. Some of these innovated technologies have been introduced to clinical settings. This review article provides summary about recent basical and clinical advances about myocardial regeneration induced by bioengineered cardiac tissue.

Keywords: Cells, heart failure, tissue engineering, myocardial regeneration


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy